Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Steel

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
Current Medical Research and Opinion|September 26, 2007
Long-term darifenacin treatment for overactive bladder in patients aged 65 years and older: analysis of results from a 2-year, open-label extension studySimon Hill, Mostafa Elhilali, Richard J Millard, et al.
The British Journal of Nutrition|January 31, 2006
A newly constructed and validated isoflavone database for the assessment of total genistein and daidzein intakeMargaret R Ritchie, John H Cummings, Michael S Morton, et al.
Expert Opinion on Drug Safety|June 3, 2021
Online information discrepancies regarding safety of medicine use during pregnancy and lactation: an IMI ConcePTION studyUlrika Nörby, Benedikte Noël-Cuppers, Sashka Hristoskova, et al.
BJU International|August 2, 2006
Long-term treatment with darifenacin for overactive bladder: results of a 2-year, open-label extension studyFrançois Haab, Jacques Corcos, Paul Siami, et al.
Health Expectations : an International Journal of Public Participation in Health Care and Health Policy|January 7, 2014
Why do women not return family history forms when referred to breast cancer genetics services? A mixed-method studyKirstie A Hanning, Michael Steel, David Goudie, et al.
Familial Cancer|July 5, 2006
Analysis of referrals to a multi-disciplinary breast cancer genetics clinic: practical and economic considerationsMarta M Reis, Dorothy Young, Lorna McLeish, et al.
International Journal of Behavioral Medicine|September 15, 2012
Lifestyle changes in women at genetic risk of breast cancer: an observational studyLorna McLeish, Marta M Reis, Clare Stewart, et al.
Breast Cancer Research : BCR|March 29, 2008
Evaluation of the current knowledge limitations in breast cancer research: a gap analysisAlastair Thompson, Keith Brennan, Angela Cox, et al.
International Journal of Cancer|May 2, 2007
Surveillance for familial breast cancer: Differences in outcome according to BRCA mutation statusPal Moller, D Gareth Evans, Marta M Reis, et al.
International Journal of Cancer|September 19, 2002
Survival in prospectively ascertained familial breast cancer: analysis of a series stratified by tumour characteristics, BRCA mutations and oophorectomyPål Møller, Ake Borg, D Gareth Evans, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Current Medical Research and Opinion|September 26, 2007
Long-term darifenacin treatment for overactive bladder in patients aged 65 years and older: analysis of results from a 2-year, open-label extension studySimon Hill, Mostafa Elhilali, Richard J Millard, et al.
The British Journal of Nutrition|January 31, 2006
A newly constructed and validated isoflavone database for the assessment of total genistein and daidzein intakeMargaret R Ritchie, John H Cummings, Michael S Morton, et al.
Expert Opinion on Drug Safety|June 3, 2021
Online information discrepancies regarding safety of medicine use during pregnancy and lactation: an IMI ConcePTION studyUlrika Nörby, Benedikte Noël-Cuppers, Sashka Hristoskova, et al.
BJU International|August 2, 2006
Long-term treatment with darifenacin for overactive bladder: results of a 2-year, open-label extension studyFrançois Haab, Jacques Corcos, Paul Siami, et al.
Health Expectations : an International Journal of Public Participation in Health Care and Health Policy|January 7, 2014
Why do women not return family history forms when referred to breast cancer genetics services? A mixed-method studyKirstie A Hanning, Michael Steel, David Goudie, et al.
Familial Cancer|July 5, 2006
Analysis of referrals to a multi-disciplinary breast cancer genetics clinic: practical and economic considerationsMarta M Reis, Dorothy Young, Lorna McLeish, et al.
International Journal of Behavioral Medicine|September 15, 2012
Lifestyle changes in women at genetic risk of breast cancer: an observational studyLorna McLeish, Marta M Reis, Clare Stewart, et al.
Breast Cancer Research : BCR|March 29, 2008
Evaluation of the current knowledge limitations in breast cancer research: a gap analysisAlastair Thompson, Keith Brennan, Angela Cox, et al.
International Journal of Cancer|May 2, 2007
Surveillance for familial breast cancer: Differences in outcome according to BRCA mutation statusPal Moller, D Gareth Evans, Marta M Reis, et al.
International Journal of Cancer|September 19, 2002
Survival in prospectively ascertained familial breast cancer: analysis of a series stratified by tumour characteristics, BRCA mutations and oophorectomyPål Møller, Ake Borg, D Gareth Evans, et al.
Pageof 3